Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa Inhibition in Complex Atherosclerotic Lesions
Fernando Cura, Eric J. Topol(Scripps Research Institute), Deepak L. Bhatt(Mount Sinai Hospital), Philippe L. L’Allier(Montreal Heart Institute), Stephen G. Ellis(Université de Perpignan), Sorin J. Brener, Samir Kapadia(Cleveland Clinic), David J. Moliterno(Cleveland Clinic), A. Michael Lincoff(Cleveland Clinic), Katherine E. Wolski(Cleveland Clinic), Khaled M. Ziada(Cleveland Clinic)
Cited by 76
Related Papers
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Long COVID: major findings, mechanisms and recommendations
|Nature Reviews Microbiology|2023|4k